Author Correction: Tocilizumab versus sarilumab among adults hospitalised with COVID-19: target trial emulation across England and Scotland.
Research paper from Europe PMC. Evidence status: source reported.
- Published
- 2026-11-04
- Source reference
- MED:42982869
- DOI
- 10.1038/s41467-026-78874-2
- Jurisdiction
- Not assessed
- Licence
- Bibliographic metadata only; article rights retained
Zheng B, Kurdi A, Amstutz A, Green A, Herrett E, Tazare J, Wen Q, Mahalingasivam V, Smith R, MacKenna B, Mehrkar A, Bacon S, Goldacre B, Robertson C, Sheikh A, Tomlinson L, OpenSAFELY Collaborative. · Nat Commun · published erratum; correction · Found via: OpenSAFELY
Source: https://europepmc.org/article/MED/42982869. Captured 2026-11-18.
Limitations: Discovered through a Europe PMC keyword search for OpenSAFELY. A mention is not a verified link to an access authorisation, project, dataset or clinical outcome. Preprints may not be peer reviewed.